At Care UK we offer free NHS treatments to all patients. You are not required to pay if you are an NHS patient and have been referred for treatment by your GP.
The Newmedica clinic treats a wide variety of eye conditions affecting all parts of the eye or eyelids. These can be medical conditions eg blepharitis, dry eye, retinal conditions or conditions needing surgery such as Entropion or Ectropion.
Cataract treatment is a surgical procedure to remove the lens which has become cloudy and replace with an artificial lens or IOL. The procedure is typically performed on an outpatient basis and does not require an overnight stay in the hospital.
Glaucoma affects approximately 1 per cent of the whole population, it is a common eye disease which needs lifelong care, usually medical and occasionally surgical (or laser).
Following cataract surgery, some patients may experience blurring due to the opacification of the capsule behind the artificial lens implant. The YAG laser can make an opening in this capsule and restore vision. This treatment is done in ONE visit.
This term covers a wide range of surgical procedures that deal with the eye socket, eyelids, tear ducts and face. It also deals with the reconstruction of the eye and its associated structures.
Wet AMD is a painless eye condition that leads to the gradual loss of central vision due to abnormal blood vessel growth. It can be treated with medication and in some cases laser surgery.
Newmedica offers YAG laser procedures as part of Glaucoma care at Barlborough NHS Treatment Centre. It can also be used to treat posterior capsule opacification after cataract surgery.
Along with all Independent Sector healthcare providers we are currently supporting NHS England during the Coronavirus crisis. This has sadly meant that any patients who were scheduled to visit us have had their treatment postponed. While we are not yet able to give patients a revised surgery date, we are doing our utmost to get through the impact of this pandemic and re-open at the earliest opportunity.
For more information on our response to the COVID-19 (Coronavirus) crisis, please view the message from our Chief Executive, Jim Easton.